Intellia Therapeutics (NTLA) Stock Price Target 2026

The average analyst price target for Intellia Therapeutics is $24.69, 120.1% above the current price. Of 24 analysts, 15 rate it Buy, 5 Hold and 4 Sell. Targets range from $5 to $65. The latest change came on Oct 6, 2026, when Barclays initiated coverage of Intellia Therapeutics with an Underweight rating and a $8 price target.